Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib for reducing severity of acute pancreatitis
IRCT20250412065298N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- May 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of celecoxib in acute pancreatitis (AP) (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: C-reactive protein. Started May 2025; status: completed.
02
Drugs
celecoxib
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on IRCT20250412065298N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250412065298N1.